FDA NDC Directory · JSON-LD · Markdown

Sucralfate

NDC 42291-781 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameSucralfate Oral
Labeler / ManufacturerAvKARE
Marketing categoryAbbreviated NDA (generic) · App ANDA209356
Dosage form / routeSUSPENSION · ORAL
Active ingredientsSUCRALFATE (1 g/10mL)
Marketing started20210416
Package count1

External sources

Source: openFDA. Public-domain (CC0).